Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 2/3 3Phase 3 2Phase 1 2Phase NA 1Phase 1/2 1

Status

Completed 11Recruiting 4Terminated 3Withdrawn 2Unknown 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 109Carcinoma, Non-Small-Cell Lung 96Prostatic Neoplasms 60Multiple Myeloma 46Neoplasms 38Neoplasm Metastasis 33Ovarian Neoplasms 26Urinary Bladder Neoplasms 24Melanoma 24Lung Neoplasms 22Recurrence 21Parkinson Disease 4, Autosomal Dominant Lewy Body 21Leukemia, Lymphocytic, Chronic, B-Cell 21Colorectal Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 17Carcinoma, Hepatocellular 17Triple Negative Breast Neoplasms 16Lymphoma, Non-Hodgkin 16Stomach Neoplasms 15Nasopharyngeal Carcinoma 15Lymphoma 14Squamous Cell Carcinoma of Head and Neck 13Small Cell Lung Carcinoma 13Fallopian Tube Neoplasms 12Colonic Neoplasms 12Carcinoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11

Interventions

Gemcitabine 2Cisplatin 2Capecitabine 2Tegafur 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Gallbladder Neoplasms × Clear all
NCT06109779 2026-03-04

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

AstraZeneca

Phase 3 Active not recruiting
757 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT02170090 2025-03-30

ACTICCA-1

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Active not recruiting
789 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡